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Vibrio cholerae O1 has two biotypes, El Tor and Classical, and the latter is now presumed to be extinct in
nature. Under carbohydrate-rich growth conditions, El Tor biotype strains produce the neutral fermentation
end product 2,3-butanediol (2,3-BD), which prevents accumulation of organic acids from mixed acid fermen-
tation and thus avoids a lethal decrease in the medium pH, while the Classical biotype strains fail to do the
same. In this study, we investigated the inhibitory effect of 2,3-BD on the production of two proinflammatory
biomarkers, intreleukin-8 (IL-8) and tumor necrosis factor alpha (TNF-), in human intestinal epithelial
HT29 and alveolar epithelial A549 cells. Cell-free culture supernatants of El Tor strain N16961 grown in LB
supplemented with 1% glucose induced a negligible amount of IL-8 or TNF-, while the Classical O395 strain
induced much higher levels of these proinflammatory cytokines. On the other hand, three mutant strains
constructed from the N16961 strain with defects in the constitutive 2,3-BD pathway were also able to induce
high levels of cytokines. When HT29 and A549 cells were treated with bacterial flagella, known proinflamma-
tory cytokine inducers, and chemically synthesized 2,3-BD at various concentrations, a dose-dependent de-
crease in IL-8 and TNF- production was observed, demonstrating the suppressive effect of 2,3-BD on the
production of proinflammatory cytokines in epithelial cells. Upon cotreatment with extraneous 2,3-BD, ele-
vated levels of IB, the inhibitor of the NF-B pathway, were detected in both HT29 and A549 cells.
Furthermore, treatments containing 2,3-BD elicited lower levels of NF-B-responsive luciferase activity, dem-
onstrating that the reduced cytokine production is likely through the inhibition of the NF-B pathway. These
results reveal a novel and potential role of 2,3-BD as an immune modulator that might have conferred a
superior pathogenic potential of the El Tor over the Classical biotype.
Cholera, an acute watery diarrheal disease, is caused by
toxigenic strains of the enteric pathogen Vibrio cholerae and is
mainly associated with consumption of contaminated water
(39). On the basis of O-antigen typing, V. cholerae has more
than 200 identified serogroups, among which only O1 and
O139 are reported to be toxigenic. Seven recent pandemics of
cholera have been caused by O1 serogroup strains, although
O139 strains were reported to be associated with Asiatic chol-
era epidemics (7, 24, 37). The O1 serogroup of V. cholerae has
further been classified into two biotypes, El Tor and Classical.
Among the seven worldwide historical pandemics, the Classical
strains are presumed to be the etiologic agent for the first six
but are only presumed to be the etiologic agent due to the lack
of ample epidemiologic surveillance, while the El Tor strains
emerged as the major cause during the ongoing seventh pan-
demic. The reasons behind the extinction of the Classical bio-
type and the emergence of the El Tor biotype remain unclear,
although several hypotheses have been proposed. The two
biotypes show significant differences in their genotypic and
phenotypic properties. A comparative genomic study revealed
that the Classical biotype strains lack more than 20 genes
found in the seventh pandemic El Tor strains, with most of
these genes located on two chromosomal islands (12). Further-
more, transcriptional profiling experiments found that 524
genes are differentially expressed between the two biotypes
under conditions that induce virulence expression in the Clas-
sical biotype. Biochemical behaviors such as hemolysis, hem-
agglutination of chicken erythrocytes (23), resistance to poly-
myxin B (18), bacteriophage-mediated lysis (4), and acetoin
synthesis (28) are used to distinguish El Tor from Classical
biotype strains. Acetoin biosynthesis in the presence of exog-
enous sugar such as glucose is crucial for biotyping the seventh
pandemic El Tor strains and O139 strains (24). El Tor strains
have a competitive growth advantage both in vitro and in vivo
in cocultures with Classical strains and express higher levels of
virulence factors in the tested cocultures (36).
A recent study showed that V. cholerae El Tor biotype strains
are associated with the production of 2,3-butanediol (2,3-BD)
through the 2,3-BD fermentation pathway, and their growth
was enhanced when they were cultured in medium with added
glucose. Classical strains, however, showed a sharp decrease in
medium pH from accumulation of organic acids, ultimately
resulting in a loss of viability. This finding suggested that the
ability to produce a neutral metabolite like 2,3-BD might ac-
count for the higher evolutionary fitness of V. cholerae El Tor
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compared to the Classical biotype (48). The finding is further
supported by the oral rehydration solution (ORS) used to treat
V. cholerae-infected patients, which contains a large amount of
glucose (16). This might aid in in vivo selection of El Tor
strains that use glucose to produce 2,3-BD, while the same
solution might have acted as a bactericidal agent for Classical
strains that lack a functional 2,3-BD synthesis pathway. How-
ever, whether the ability to produce 2,3-BD provides any ad-
ditional benefit to El Tor strains in the modulation of the host
immune system has never been investigated.
The capability to produce the low-molecular-weight hydro-
carbon 2,3-BD from pyruvate is widely distributed among dif-
ferent bacterial species, including all species of Serratia and
Enterobacter, as well as some species of Klebsiella, Erwinia,
Bacillus, and Aeromonas (44). In Aeromonas spp., another
member of the Vibrionaceae family, it has been shown that
2,3-BD production depended on quorum sensing and that its
production prevented lethal acidification of the medium (21).
Previous studies showed that 2,3-BD is involved in a variety of
physiological activities and is used across a broad spectrum
of industrial applications, including as a homeostatic agent of
environmental pH when bacterial cells are grown to higher cell
densities (21), for regulation of the cellular NAD/NADH ratio
(28), as a biomarker of ethanol abuse (34), and as biofuel (30).
Although a number of studies have examined and character-
ized 2,3-BD production, its interaction with mammalian hosts
and whether it plays any role in pathogenesis remain unclear.
Recently, a study showed that chemically synthesized 2,3-BD
can suppress lipopolysaccharide-induced host inflammatory re-
sponses in a rat acute lung injury model through inhibition of
the nuclear factor B (NF-B) signaling pathway (22).
V. cholerae flagellins induce the inflammatory cytokines in-
terleukin-1 (IL-1), IL-6, and tumor necrosis factor alpha
(TNF-) and the chemokine IL-8 in intestinal epithelial cells
through the Toll-like receptor 5 (TLR5)-dependent NF-B
and mitogen-activated protein kinase (MAPK) signaling path-
way (2, 19, 49). V. cholerae in vivo infection in mice demon-
strated that the local inflammation was activated, as evidenced
by elevated secretion of TNF- and IL-1 (17), which ulti-
mately mediates a wide range of inflammatory responses (9).
Thus, for successful colonization and production of virulence
factors, pathogenic organisms must adopt certain mechanisms
to bypass or suppress the host inflammatory responses that
ultimately lead to the activation of antipathogen defense.
Keeping this in mind, this study was designed to elucidate
another crucial physiological role of 2,3-BD with respect to the
emergence of the El Tor biotype strains. We hypothesized that
the metabolite 2,3-BD, which is exclusively produced in El Tor
biotype strains, might be involved in modulating the way in
which host immune defense is activated and thereby in con-
tributing to the higher virulence potential of the El Tor over
the Classical biotype. We found that 2,3-BD exerted a clear
suppressive effect on the induction of two proinflammatory
cytokines, IL-8 and TNF-, in two distinct human epithelial
cells. Subsequent analysis also revealed that such reduction
occurred most likely through the inhibition of NF-B sig-
naling. Conversely, Classical strains grown in LB supple-
mented with 1% glucose (LBG) induced very high levels of
IL-8 and TNF-. Our study provides insight into how a
metabolite produced by the El Tor biotype strain is capable
of modulating local inflammation at the site of infection.
This insight may offer a clue to explain the present domi-
nance of El Tor biotype as a causal pathogen in cholera. A
better understanding of this mechanism would answer a
long-standing mystery regarding the environmental adapt-
ability and biotype switching of this deadly pathogen.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. All strains and plasmids
used in this study are listed in Table 1. Bacterial cultures were grown at 37°C in
LB (10 g tryptone, 5 g NaCl, and 5 g yeast extract per liter) and LB medium
supplemented with 1% glucose (Sigma Chemical, St. Louis, MO) with shaking,
unless otherwise stated.
Preparation of cell-free culture supernatants. Cell-free culture supernatants
were prepared as described elsewhere (47). Briefly, 3 ml of an overnight (16-h)
shaking culture of V. cholerae strains was grown to an optical density (OD) at 600
nm (OD600) of4 (except for the O395 strain grown in LBG medium, which had
an OD of 1.8 at a similar time point) and centrifuged at 13,000 rpm for 10 min,
and the supernatant was passed through a 0.22-m-pore-size syringe filter (Pall
Corp., MI). Cell-free supernatants were used immediately or stored at 20°C.
Cell culture, reagents, and stimulation. The intestinal epithelial HT29 and
alveolar epithelial A549 cell lines (ATCC, Manassas, VA) were cultured in
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Serogroup, biotype (serotype) Relevant characteristic(s) Reference or source
V. cholerae strains
N16961 O1, El Tor (Inaba) Wild type 12
O395 O1, Classical (Ogawa) Wild type 12
SSY01 O1, El Tor (Inaba) N16961 VC1590::TnKGL3 48
SSY02 O1, El Tor (Inaba) N16961 VC1589 48
SSY05 O1, El Tor (Inaba) N16961 VC2614::TnKGL3 This study
Escherichia coli strain
DH5a
supE44 (lacU169) (80dlacZM15) hsdR17 recA1 endA1
gyrA96 thi-1 relA1
Lab collection
Plasmids
pRL SV40b pRL family of Renilla luciferase control reporter vector, Apr Promega Inc.
3	 MHCc-luc Three copies of MHC I enhancer NF-B-responsive
elements TGGGGGATTCCCCA upstream of the lucifer-
ase (luc) reporter gene, Apr
Lab collection
a Used to amplify luciferase reporter plasmids.
b SV40, simian virus 40.
c MHC, major histocompatibility complex.
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Dulbecco’s modified Eagle medium (DMEM) and minimum essential medium
(MEM), respectively, supplemented with 10% fetal bovine serum (FBS; Wel-
GENE, South Korea), 2.5 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml
streptomycin at 37°C under 5% CO2 in a water-jacketed CO2 incubator (Forma
Scientific). The 2,3-BD (99.8%) was purchased from Sigma-Aldrich Chemie
GmbH (Steinheim, Germany). Fugene6 transfection reagent was from Roche
Applied Science (Mannheim, Germany). All expression plasmid constructs were
prepared using an Accuprep plasmid extraction kit (Bioneer, South Korea).
IB rabbit monoclonal antibody was from Cell Signaling Technology (Danvers,
MA). Secondary antibody was horseradish peroxidase (HRP)-conjugated goat
antirabbit antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA). For stim-
ulation with bacterial cell-free culture supernatants, 2 	 104 host cells were
seeded in each well of 96-well plates (SPL Life Sciences, South Korea) and
cultured overnight. On the next day, culture medium was replaced with serum-
free medium before treatment. Ten microliters of prepared culture supernatants
from bacterial cultures was added to cultured host cells and the cells were
incubated for 6 h at 37°C under 5% CO2. HT29 and A549 cells were incubated
with 2,3-BD, added to the supernatants at a concentration of 1%, 0.5%, or 0.1%,
as indicated. Samples for IL-8 and TNF- ELISAs were collected, and cell
viability was measured using Cell Counting Kit-8 (CCK-8; Dojindo Laboratories,
Kumamoto, Japan) or 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide (MTT; Sigma Chemical, St. Louis, MO) according to the manufactur-
er’s instructions.
Purification and extraction of V. cholerae flagella. Flagella from V. cholerae El
Tor strain N16961 were prepared following the method described previously
(49), with slight modifications. LB agar plates were inoculated with V. cholerae
N16961 and incubated at 37°C overnight. The plates were scraped, and bacteria
were inoculated in 1,000 ml LB broth and grown with continuous shaking for
overnight in a shaking incubator. Bacteria were pelleted by centrifugation at
15,600 	 g for 10 min, and the pellet was resuspended in 50 ml phosphate-
buffered saline (PBS; pH 7.4). For flagellum purification, the bacterial cell
suspension was mechanically sheared using a Waring blender for 1 min at full
speed. Bacterial cells and other components were removed by centrifugation at
10,000 rpm for 10 min (Sorvall Science, Buckinghamshire, United Kingdom).
The supernatant containing flagella was further centrifuged at 210,000 	 g for 90
min at 4°C using an ultracentrifuge with a SW41 rotor (Beckman). The flagellum
pellet was resuspended in phosphate-buffered saline and subjected to 1.37-g/ml
CsCl density gradient ultracentrifugation at 100,000 	 g for 18 h at 25°C. On the
next day, the flagellum band was isolated by syringe and dialyzed against water
overnight. The purity of the flagella was assessed by sodium dodecyl sulfate
(SDS)-polyacrylamide gel electrophoresis (PAGE), and the protein concentra-
tion was measured by the Bradford method using a Bio-Rad Inc. (CA) protein
assay solution with bovine serum albumin as a standard.
Quantification of 2,3-BD in bacterial culture supernatant by GC-MS. 2,3-BD,
produced in laboratory culture (LB plus 1% glucose) by the V. cholera El Tor
N16961 strain, was resolved and quantified by gas chromatography (GC)-mass
spectrometry (MS) using an Agilent 6890 Plus gas chromatograph equipped with
a 5973N mass selective detector quadrupole mass spectrometer system (Palo
Alto, CA). The DB-5 MS capillary column (30 m by 0.25 mm [inner diameter],
0.25-m film thickness, 5% diphenyl–95% dimethylsiloxane phase) was obtained
from J&W Scientific (Folsom, CA). Sample preparation was performed as de-
scribed elsewhere (38). Briefly, 1 ml of each sample was mixed with 1 ml of a
0.05% aqueous standard solution of 1,4-butandiol, alkalinized to pH 10, ex-
tracted with 6 ml of ethyl acetate (Sigma, St. Louis, MO), concentrated to 0.2 ml,
and injected (1 l) in the GC-MS system in the split mode at a splitting ratio of
1:10. The GC oven temperature was maintained at 60°C for 1 min and then
ramped to 290°C at 10°C per min. The temperatures of the GC injection port and
MS interface were set at 250 and 280°C, respectively. The carrier gas used was
helium, set at a constant flow rate of 1 ml/min. The mass selective detector was
run in the electron impact (EI) mode, with the electron energy at 70 eV. The silyl
derivatization and selected ion monitoring (SIM) mode were used to remove the
interferences for the quantification analysis.
IL-8 and TNF- assay. After treatment, the HT29 and A549 cell culture
supernatants were collected and stored at 80°C. The levels of IL-8 and TNF-
production by both cell lines were determined using HU IL-8 and HU TNF-
CytoSet enzyme-linked immunosorbent assay (ELISA) kits (Invitrogen Corp.,
CA) according to the manufacturer’s instruction, and the titers were expressed as
pg/ml.
NF-B reporter assay. HT29 cells were seeded (3 	 105 cells/well) and stably
transfected with two luciferase reporter constructs according to the manufactur-
er’s cell line-specific instructions. Optimized amounts of NF-B-responsive fire-
fly luciferase plasmid (0.2 g) and transfection control Renilla luciferase plasmid
(0.1 g) were used. Cells were allowed to recover for at least 24 h in fresh
medium without antibiotics and were stimulated with 50 l V. cholerae culture
supernatants (prepared as described above) or various concentrations of purified
V. cholerae flagella in 24-well plates (SPL Life Science, South Korea). Luciferase
activity was measured using a Dual luciferase reporter assay kit (Promega Corp.,
Madison, WI) according to the manufacturer’s protocol. A Victor Plus plate
reader (Perkin-Elmer) was used to measure luciferase activity. Firefly luciferase
activity was normalized with Renilla luciferase activity and expressed as relative
light units (RLU).
Western blot analysis. HT29 and A549 cells at 90% confluence were seeded
at 105 cells/well in each well of 24-well plates (SPL Life Sciences, South Korea),
treated with diverse stimuli for specified time intervals for up to 2 h, and lysed
with 1	 sample lysis buffer (62.5 mM Tris-HCl, pH 6.8, at 25°C, 2% [wt/vol] SDS,
10% glycerol, 50 mM dithiothreitol, 0.01% [wt/vol] bromophenol blue or phenol
red). After lysis, cells were scraped off, kept on ice, and boiled for 5 min. After
they were cooled on ice, samples were microcentrifuged for 5 min. Equal
amounts of total protein (50 g proteins per gel lane) were separated by SDS-
PAGE on 12% gels and transferred to polyvinylidene difluoride membranes
(Amersham Hybond-ECL; GE Healthcare). Membranes were blotted with rab-
bit anti-human IB immunoglobulin G (Cell Signaling) or mouse anti-human
-actin immunoglobulin G (Sigma-Aldrich, Steinheim, Germany) at 4°C over-
night, followed by incubation with HRP-conjugated secondary antirabbit or
antimouse antibodies (Santa Cruz Biotechnology). The immunoreactive protein
bands were then visualized using the enhanced chemiluminescence (ECL) re-
agent Westsave Up (Ab Frontier).
Fluorometric NO assay. Nitric oxide (NO) production by HT29 cells was
determined by measuring the level of nitrite, a stable oxidation product of NO,
by use of the Griess reagent (Invitrogen, Eugene, OR). HT29 and A549 cells
(2 	 106 cells) were treated with gamma interferon (IFN-
; 300 U/ml) and
TNF- (100 ng/ml) in the presence or absence of 1% 2,3-BD. The amount of
nitrite produced was expressed in M.
Statistical analysis. Data are expressed as means standard deviations (SDs).
An unpaired Student’s t test was used to analyze the data. A P value of0.05 was
considered statistically significant. All the experiments were repeated for repro-
ducibility.
RESULTS
Culture supernatants of LBG-grown N16961 induced signif-
icantly lower levels of IL-8 and TNF- in epithelial cells than
culture supernatants of O395. V. cholerae El Tor strains were
represented by strain N16961, and Classical strains were rep-
resented by strain by O395. Both strains have been extensively
studied, and the genomic sequences are well characterized.
Filter-sterilized culture supernatants of N16961 or O395 grown
in either LB or LBG medium were used to treat HT29 and
A549 cells as described in Materials and Methods. As shown in
Fig. 1A and B, 6-h treatments induced production of proin-
flammatory cytokines in markedly different ways. The culture
supernatant from LBG-grown N16961 induced negligible
amounts of IL-8 (40 pg/ml) or TNF- (15 pg/ml) in the
HT29 cell line. In contrast, the culture supernatant from the
LBG-grown Classical O395 strain induced a significantly
higher level of IL-8 (400 pg/ml) and TNF- (93 pg/ml), as
determined by ELISA, although the organism grew poorly in
the medium. At the same time, HT29 cells treated with LB-
grown N16961 culture supernatants induced very low levels of
IL-8 or TNF- secretion (Fig. 1A and B), because this treat-
ment showed a clear cytotoxic effect on the epithelial cells. For
this reason, this culture supernatant was not used further in
this study. To eliminate the possibility that the elevated pro-
duction of IL-8 (Fig. 1A) is mediated by the effect of acidified
medium pH, O395 was cultured in phosphate-buffered LBG
medium. The medium pH was found to be stable at about
neutral (7.5) after 16 h growth, while the pH of the medium of
the LBG-grown Classical strain was 4.5 under the same con-
ditions (data not shown). The culture supernatant from buff-
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ered medium was still able to induce higher levels of IL-8 (Fig.
1C). In addition, the LBG-grown Classical strain continued to
give higher signals for IL-8, even when the medium pH was
manually adjusted to neutrality (pH 7.0) after overnight growth
by the addition of 0.1 N sodium hydroxide (Fig. 1C). All these
experiments were repeated with alveolar epithelial A549 cells,
and similar patterns of IL-8 and TNF- induction were ob-
served (see Fig. S1 in the supplemental material).
Suppressed cytokine production by the LBG-grown N16961
supernatant was not associated with a change in HT29 cell
viability. We then examined whether the reduced production
of IL-8 and TNF- in response to the supernatant of LBG-
grown N16961 was mediated by the altered host cell viability.
As shown in Fig. 2A, the culture supernatant of LB-grown
N16961 was completely cytotoxic to HT29 cells, as determined
by the CCK-8 cell viability assay. This observation was further
verified in our microscopic analysis. After only 2 h of treat-
ment, 90% cells were vacuolated and necrotic death oc-
curred, as shown Fig. 2B. In contrast, such a cytotoxic effect
was completely absent or negligible when cells were treated
with the supernatant of LBG-grown N16961 or with superna-
tants of O395 (Fig. 2A). Consistent with the CCK-8 assay
results, no difference in cellular morphology was observed in
HT29 cells responding to the LBG-grown N16961 supernatant
and to the control treatment (Fig. 2C and D). Together, these
observations demonstrated that the decreased production of
proinflammatory cytokines by the treatment with the LBG-
grown N16961 supernatant was not a consequence of any
change in host cell viability. Similar to the viability pattern
observed with HT29 cells, only the LB-grown N16961 super-
natant was cytotoxic to A549 cells (see Fig. S2 in the supple-
mental material).
Production of higher levels of IL-8 and TNF- by 2,3-BD-
defective N16961 mutants and O395 was reversed by the ad-
dition of extraneous 2,3-BD. We then sought to examine
whether the El Tor biotype-specific glucose metabolite 2,3-BD
was responsible for the downregulated production of IL-8 and
TNF-. To address this question, we tested the immune-stim-
ulating capability of three N16961-derived mutant strains that
are defective in 2,3-BD synthesis (48). Detailed information on
these mutant strains is listed in Table 1. Similar to the O395
Classical biotype strain, each of these mutant strains was un-
able to produce 2,3-BD using glucose and thus was significantly
affected in its ability to grow in glucose-amended medium
(data not shown). Unlike the wild-type N16961 strain, super-
natants of these LBG-grown mutant strains invariably stimu-
lated the production of higher levels of the proinflammatory
FIG. 1. Differential IL-8 and TNF- production in HT29 cells in response to the culture supernatants of V. cholerae El Tor and Classical biotype
strains. HT29 cells seeded in 96-well plates at 2 	 104 cells per well were treated for 6 h with culture supernatants of El Tor N16961 or Classical
O395 grown in LB or LBG. IL-8 (A) and TNF- (B) levels in culture supernatants were measured by ELISA, and values of means  SDs are
displayed in each bar (n  4). ***, P  0.001 for a comparison between LBG-grown O395 and LBG-grown N16961 supernatant treatments.
(C) IL-8 production in response to treatment with O395 culture supernatants. O395 was grown in LBG (black bar) or in pH-buffered LBG (gray
bar). The pH of the LBG-grown O395 culture supernatant was also adjusted with 0.1 N NaOH before treatment (white bar).
FIG. 2. Viability of HT29 cells in response to treatments with cul-
ture supernatants. (A) CCK-8 assay showing HT29 cell viability with
indicated treatments for 6 h. Values of means  SDs are displayed in
each bar, and the medium composition is indicated at the bottom.
Microscopic images of HT29 cells treated with the supernatant of
LB-grown N16961 (B), with the supernatant of LBG-grown N16961
(C), or with DMEM (D).
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cytokines IL-8 and TNF-. As shown in Fig. 3A and B, HT29
cells secreted up to200 pg/ml of IL-8 and up to70 pg/ml of
TNF- when they were treated with filter-sterilized culture
supernatants of these mutant strains (Fig. 3A and B, gray bars).
As was observed in O395 (Fig. 1A and B), supernatants of
LB-grown strains were not as potent as supernatants of LBG-
grown strains in inducing IL-8 and TNF- production (Fig. 3A
and B, black bars). To examine the effect of 2,3-BD on IL-8
and TNF- production, HT29 cells were treated with the LBG-
grown strain supernatants that were devoid of 2,3-BD but
reconstituted with 0.5% (blue bars) and 1% (green bars) 2,3-
BD. As shown in Fig. 3A and B, levels of IL-8 or TNF-
production were significantly decreased by the addition of ex-
traneous 2,3-BD. Again, no reduction in host cell viability was
observed in response to the treatment (see Fig. S3 in the
supplemental material), further demonstrating that the re-
duced production of proinflammatory cytokines was not
caused by any change in host cell viability. Use of A549 cells to
observe the effects of extraneous 2,3-BD on the production of
IL-8 and TNF- provided similar outcomes, as shown in Fig.
S4 in the supplemental material.
Next, we applied 2,3-BD extraneously while treating HT29
cells with culture supernatant of LBG-grown O395 to observe
if the added 2,3-BD could also modulate the ability to produce
proinflammatory cytokines. After 6 h treatment, we detected a
marked decrease in the production of IL-8 and TNF-, and the
decrease was dose dependent (Fig. 4A and B, right portions).
Such findings, which were similar to those for the 2,3-BD-
defective N16961 mutant strains, further supported the role of
2,3-BD as a negative regulator for the production of proin-
flammatory cytokines. Again, the supernatant of the O395
strain grown in plain LB, which also induced the production of
intermediate levels of IL-8 and TNF-, was less efficient in
doing the same in the presence of extraneous 2,3-BD (Fig. 4A
and B, left portions). Together, these data demonstrated the
involvement of 2,3-BD in suppressing the production of pro-
inflammatory cytokines in vitro. As before, these data were
successfully reproduced using A549 cells (see Fig. S5 in the
supplemental material).
Quantification of 2,3-BD produced by N16961 in the pres-
ence of glucose. We then sought to gain an idea of how much
2,3-BD can be produced biologically from the El Tor V. chol-
erae biotype strain during growth with 1% glucose. To this end,
we analyzed the bacterial culture supernatants by GC-MS. As
shown in Table 2, 28 mM 2,3-BD was detected in the LBG-
grown N16961 culture supernatant, while a 20-fold smaller
amount of 2,3-BD was detected in the LB-grown N16961 su-
pernatant, further proving that 2,3-BD is produced by glucose
fermentation. As expected, negligible levels of 2,3-BD were
detected in O395 culture supernatants. Given the fact that 1%
glucose is equivalent to 56 mM, this result indicated that
FIG. 3. Treatments with culture supernatants of 2,3-BD-defective
N16961 mutant strains resulted in production of higher levels of IL-8
(A) and TNF- (B). Values of means  SDs (n  4) are displayed in
each bar. The strain and medium composition are indicated at the
bottom. Three mutant strains were grown in LB (black bars) or LBG
(gray bars). Aliquots of supernatants of LBG-grown strains were mixed
with 2,3-BD to a final concentration of 0.5% (blue bars) or 1% (green
bars) prior to the treatment. **, P  0.01 for comparison (i) between
values of gray and blue bars and (ii) between values of blue and green
bars. The leftmost set of bars shows the levels of cytokines produced by
the supernatants of wild-type strain N16961, and the rightmost bar
shows the levels for the unstimulated medium control.
FIG. 4. Suppressed production of IL-8 and TNF- by O395 super-
natants in the presence of extraneous 2,3-BD in HT29 cells. Culture
supernatants of LB- and LBG-grown O395 were used to stimulate
HT29 cells. Each supernatant was mixed with 2,3-BD at a final con-
centration of 0.5% or 1%. A statistically significant decrease in IL-8
(A) or TNF- (B) production was observed when 2,3-BD was added.
IL-8 and TNF- levels were determined by ELISA, and values of
means  SDs (n  4) are displayed in each bar. *, P  0.05 for
comparison between supernatants without 2,3-BD and supernatants
reconstituted with extraneous 2,3-BD; **, P  0.01 for comparison
between supernatants without 2,3-BD and supernatants reconstituted
with extraneous 2,3-BD.
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about half of the glucose was metabolized to produce 2,3-BD,
which represents a metabolic conversion with a considerable
yield rate.
2,3-BD downregulated the level of cytokines produced in
response to the purified flagella in a dose-dependent manner.
We then examined whether 2,3-BD can also suppress the pro-
duction of IL-8 in response to the purified V. cholerae flagella,
known inducers of the TLR5-mediated innate immune re-
sponse (19). Flagella extracted from the V. cholerae El Tor
N16961 strain were used as a positive control to induce IL-8
production in HT29 cells. When they were treated with in-
creasing concentrations of purified flagella, HT29 cells se-
creted IL-8 at levels ranging from 200 to 350 pg/ml (Fig. 5,
black bars). Again, when HT29 cells were cotreated with var-
ious concentrations of 2,3-BD, a pattern of gradual decrease in
IL-8 secretion by the addition of increasing amounts of 2,3-BD
was observed in all sets of flagellum treatments (Fig. 5, gray
and white bars), further demonstrating that 2,3-BD can sup-
press the proinflammatory cytokine production in cultured
host epithelial cells. A similar dose-dependent decrease in IL-8
production was also observed in A549 cells when they were
cotreated with 2,3-BD (see Fig. S6 in the supplemental mate-
rial).
2,3-BD-mediated downregulation of cytokine production oc-
curred by inhibition of NF-B signaling pathway. Next, we
investigated whether the underlying mechanism of 2,3-BD-
induced cytokine downregulation was targeting the transcrip-
tion factor NF-B, which is involved in the production of a
number of proinflammatory cytokines, including IL-8 and
TNF- (45). To address this issue, we assessed the level of
IB protein, an inhibitor of NF-B activation (6, 45), by
Western blotting. In all cases, -actin was used as a loading
control. As shown in Fig. 6A, an increased level of IB pro-
tein was detected with time after treatment with culture super-
natants of the LBG-grown N16961. However, treatment with
LBG-grown O395 supernatants, which induced a high level of
production of IL-8 and TNF- in HT29 cells, resulted in a
time-dependent gradual decrease in the IB protein (Fig.
6B). When the same supernatant was reconstituted with extra-
neous 2,3-BD, a similar pattern for the elevated presence of
IB was observed during the first 2 h of treatment (Fig. 6C).
Likewise, when HT29 cells were treated with purified flagella,
which also induced high-level IL-8 production (Fig. 5), a de-
creased level of IB protein was detected (Fig. 6D). Again,
cotreatment with 1% 2,3-BD completely reversed the trend for
the cellular levels of IB (Fig. 6E). Collectively, these results
demonstrated that (i) IB degradation occurred in HT29
cells in response to the treatments that induced a high level of
IL-8 production, and (ii) the sole addition of 2,3-BD is enough
to inhibit the time-dependent degradation of the IB protein.
Apparently, similar or comparable IB degradation patterns
were observed in A549 cells in response to the identical set of
treatments (see Fig. S7 in the supplemental material). We then
examined whether the modulation of the IB level was in-
TABLE 2. Levels of 2,3-BD produced by N16961 and O395 strains
grown in different culture media determined by GC-MS
Strain-growth medium 2,3-BD concn (mM)
O395-LB .......................................................................0.15  0.01
O395-LBG....................................................................0.28  0.012
N1696-LB .....................................................................1.34  0.05
N1696-LBG .................................................................. 28  0.12
FIG. 5. IL-8 production in response to purified flagella was also
downregulated by exogenously added 2,3-BD. Purified V. cholerae fla-
gella at final concentrations of 100 g/ml, 10 g/ml, 1 g/ml, and 100
ng/ml were used to stimulate HT29 cells. IL-8 levels in the HT29 cell
culture supernatants were determined by ELISA, and values of
means  SDs (n  4) are displayed in each bar. Aliquots of each
flagellum preparation were mixed with 2,3-BD at final concentrations
of 0.5% and 1% and used to treat HT29 cells. **, P  0.01 for
comparison between flagellum-only treatment and treatment with fla-
gella plus 1% 2,3-BD.
FIG. 6. Effect of extraneous 2,3-BD on the cellular levels of
IB. (A) Anti-IB Western blot analysis of HT29 cell extracts.
Before harvest, HT29 cells were treated with LBG-grown N16961
supernatant for 2 h. At the times indicated at the top, HT29 cells
were harvested and processed for the Western blotting. The -actin
level was monitored as a loading control. (B) Anti-IB Western
blot analysis of HT29 cells treated with LBG-grown O395 superna-
tant; (C) anti-IB Western blot analysis of HT29 cells treated with
LBG-grown O395 supernatant plus 1% 2,3-BD; (D) anti-IB
Western blot analysis of HT29 cells treated with purified flagella;
(E) anti-IB Western blot analysis of HT29 cells treated with
purified flagella plus 1% 2,3-BD.
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deed reflected in the NF-B-responsive promoter activity. To
address this question, we measured the activity of firefly lucif-
erase, production of which was regulated by activated NF-B.
Supernatants from the LBG-grown El Tor N16961 strain
caused the weakest light production response of all treatments,
as shown in Fig. 7. A much greater NF-B-responsive pro-
moter activity was observed upon treatments with the super-
natants of LBG-grown O395, SSY05, SSY01, or SSY02, which
lacked 2,3-BD. Similar luciferase activity was also detected in
response to the purified flagella (Fig. 7). Importantly, a signif-
icantly decreased level (P  0.01) of luciferase activity was
observed when pretransfected HT29 cells were cotreated with
exogenously added 2,3-BD (Fig. 7, gray bars). The light re-
sponses were comparable to those from the treatment with
2,3-BD-containing LBG-grown N16961 supernatant.
Finally, to further support the suggestion that 2,3-BD
interferes specifically with the signaling cascade that in-
volves NF-B activation, we examined whether 2,3-BD also
exerts any effect upon epithelial cells, which were stimulated
by IFN-
 (300 U/ml) and TNF- (100 ng/ml) to produce
NO. When HT29 cells were stimulated with these two cyto-
kines, they were reported to produce NO through a distinct
pathway known as the inducible nitric oxide synthase
(iNOS) pathway (26, 33). As shown in Fig. S8 in the sup-
plemental material, similar levels of NO2 were produced in
the IFN-
- and TNF--primed HT29 cells, regardless of the
presence or absence of 2,3-BD, indicating that the signaling
cascade leading to the activation of the iNOS pathway was
not affected by the addition of 2,3-BD. Taken together,
these results further support the suggestion that the 2,3-BD-
mediated cytokine downregulation is mediated by the selec-
tive inhibition of the NF-B signaling pathway.
DISCUSSION
A unique event in cholera epidemiology was the displace-
ment of the epidemic-causing Classical biotype of V. cholerae
with the El Tor biotype. This occurred within a decade of the
emergence of the El Tor biotype in 1961, marking the begin-
ning of the seventh cholera pandemic (13). The genetic basis or
environmental factors behind this population switch are still
unknown, despite many new findings on the molecular-level
differences between the El Tor and the Classical biotypes (3,
12, 31). A marked difference in the glucose metabolism be-
tween the El Tor and Classical biotype strains provided insight
for solving this long-standing mystery (48). In the present
study, we focused on the additional benefit provided to V.
cholerae El Tor biotype strains by the El Tor biotype-specific
metabolic end product 2,3-BD.
V. cholerae can stimulate secretion of proinflammatory cy-
tokines and chemokines, which are important factors in disease
pathology (40). Establishing mechanisms to suppress produc-
tion of proinflammatory cytokines might be crucial for success-
ful infection of the host by V. cholerae. We observed substantial
differences in IL-8 and TNF- production in two distinct epi-
thelial cell lines in response to the cell-free culture superna-
tants of V. cholerae El Tor and Classical biotype strains. Be-
cause 2,3-BD is produced by the El Tor but not by the Classical
biotype strain in glucose-amended cultures, we hypothesized
that the significantly reduced production of IL-8 and TNF- by
the El Tor N16961 culture supernatant might be caused by the
presence of 2,3-BD.
In V. cholerae, production of virulence factors is strongly
influenced by environmental signals, such as pH and temper-
ature (42). Recently, a PadR family-type transcriptional regu-
lator, AphA, an activator of the tcpPH promoter, was shown to
repress the expression of genes for 2,3-BD synthesis by directly
binding to the transcriptional start site of alsD (VC1589),
the first gene in the 2,3-BD pathway gene cluster. Expres-
sion of biosynthetic genes was derepressed by AlsR
(VC1588), the regulator gene for the 2,3-BD pathway which
is activated upon acidification (28). These findings suggest
that AphA, coupled with AlsR, can reciprocally regulate
virulence gene expression and 2,3-BD biosynthesis in re-
sponse to the pH change. Thus, AphA-dependent gene reg-
ulation may be more active in Classical biotype strains,
ultimately leading to greater suppression of the 2,3-BD syn-
thesis pathway in Classical biotype strains than in El Tor
biotype strains. Thus, elevated production of IL-8 and
TNF- in epithelial cells in response to the LBG-grown
O395 culture supernatant could be caused by (i) a higher
level of secretion of immunostimulatory virulence factors
like cholera toxin (40) and/or (ii) the absence of 2,3-BD,
which can downregulate proinflammatory cytokine produc-
tion.
LB-grown culture supernatants of N16961 were cytotoxic
for epithelial cells within 2 h of treatment. Other studies
hypothesized that this phenomenon is more likely exerted by
toxins such as hemolysin or other accessory toxins produced
predominantly by El Tor strains (14, 15, 32). When the El
Tor strains were grown with 1% added glucose, however, the
cytotoxic effect was not observed or, if it was present, was
observed only occasionally at a negligible level (5% com-
FIG. 7. Effect of extraneous 2,3-BD on NF-B-responsive lucifer-
ase activity. A total of 3 	 105 cells per well cotransfected with pRL
SV40 (simian virus 40) and 3	 MHC (major histocompatibility com-
plex)-luc firefly luciferase reporter plasmids were treated with the
stimuli indicated at the bottom. Luciferase activity was determined by
using a dual luciferase assay system. Experiments were performed in
triplicate, and values of means  SDs are displayed for each bar.
NF-B-responsive luciferase activity was expressed in RLU by normal-
izing firefly luciferase activity with constitutive Renilla luciferase activ-
ity. **, P  0.01 for comparison between without and with extrane-
ously added 2,3-BD.
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pared to the untreated control). Although more experiments
are necessary to precisely uncover the molecular basis be-
hind this differential cytotoxicity, it is likely that a metabolic
shift induced by the presence of glucose might also play a
role in downregulating the expression of virulence-associ-
ated genes.
To provide insight into the possible role of 2,3-BD in mod-
ulating the immune response inside the human host, it would
be desirable to know more about the production yield of
2,3-BD from glucose catabolism. Our results in Table 2 showed
that the level of 2,3-BD produced from 1% glucose (56 mM)
was 28 mM, a value equivalent to 0.25%, and this result is in
accordance with previous findings (48). During the study, we
have used chemically synthesized 2,3-BD at levels up to 1%, a
concentration 4-fold higher than the level of 2,3-BD produced
biologically from 1% glucose. In fact, 1% 2,3-BD was required
to downregulate the production of proinflammatory biomark-
ers like IL-8 or TNF-. Therefore, the use of such a higher
concentration of 2,3-BD to cotreat host cells requires justifi-
cation. Cholera patients with severe dehydration have usually
been administered standard ORS every 4 h, according to
WHO recommendations (46); standard ORS contains 111 mM
glucose, twice the concentration used in the present study.
Thus, although this possibility is speculative, continuous con-
sumption of ORS may have created a microenvironment in the
stomach or intestine with a higher level of glucose that may
have imposed a selective pressure on various V. cholerae
strains. In this sense, there is a possibility that the level of
2,3-BD produced in the intestine is much greater than that
produced by in vitro culture in the defined medium with a
single dose of glucose.
To further characterize the effect of 2,3-BD on cytokine
production, we used three 2,3-BD-defective N16961 mutant
strains (48). Two of the three mutant strains, SSY01 and
SSY02, were lacking two vital open reading frames, VC1589
(acetolactate synthase, alS) and VC1590 (acetolactate decar-
boxylase, alD), of the 2,3-BD pathway. The third mutant strain,
SSY05, is defective in VC locus 2614, which codes for the
global regulator cyclic AMP receptor protein (CRP). CRP is
indirectly involved in glucose metabolism and in the regulation
of 2,3-BD pathway genes (5, 27, 29, 31). These strains were
found to exhibit reduced growth in the presence of added
glucose, similar to the growth of O395, due to the medium
acidification. Of note, cell-free culture supernatants of
N16961-derived mutant strains SSY01, SSY02, and SSY05
consistently induced high levels of IL-8 and TNF- that were
almost comparable to the response of O395 to the culture
supernatant (Fig. 3), suggesting that these mutants behave like
O395, at least in terms of stimulating the production of pro-
inflammatory cytokines in cultured epithelial cells. Again, ex-
traneously added 2,3-BD clearly downregulated IL-8 and
TNF- production, as was observed for the LBG-grown
N16961 supernatant containing 2,3-BD. Therefore, the pres-
ence of a functional 2,3-BD pathway is vital for the El Tor
biotype strains to modulate the level of proinflammatory cyto-
kine production in vitro.
Increasing evidence suggests that flagellin monomers are
released into the culture medium (2, 19, 47). Since bacterial
flagella are known activators of innate immunity (43), we ex-
amined whether 2,3-BD can still exert a similar inhibitory ef-
fect in HT29 or A549 cells in response to the purified V.
cholerae flagella. We extracted flagella from the V. cholerae El
Tor N16961 strain and used them as an inducer of IL-8. At 100
g/ml to 100 ng/ml, the flagellum fraction indeed induced high
levels of IL-8 in HT29 cells, and when they were cotreated with
various concentrations of 2,3-BD, a dose-dependent decrease
in IL-8 levels was observed, further suggesting a clear inhibi-
tory effect of 2,3-BD on the induction of the proinflammatory
cytokine IL-8.
Next, we investigated the mechanism by which 2,3-BD exerts
suppressive action on cytokine release in cultured epithelial
cells. IL-8 expression involves activation of the MAPKs, c-Jun
N-terminal kinase (JNK), and extracellular-regulated kinase
(ERK), as well as the transcription factors NF-B and activator
protein 1 (AP-1) (20, 35). Among these, the NF-B pathway
has long been known to be involved in the central regulation of
proinflammatory responses (10). Therefore, we performed ex-
periments to see if this particular pathway is affected by the
presence of 2,3-BD. The IB protein family contains inhibitors
of NF-B. IB binds NF-B in the cytoplasm and prevents its
translocation to the nucleus (11, 45). Thus, measuring the
cytoplasmic level of IB provides an indirect but recognized
method for monitoring the inhibition level of the NF-B-
mediated signaling cascade (1). We found that degradation
of IB was apparent during the treatment and lasted for up
to 2 h after host epithelial cells were treated with culture
supernatants that lacked in 2,3-BD. In contrast, levels of
IB increased and reached their highest level at between 1
and 2 h in treatments with culture supernatants of LBG-
grown N16961 or flagella plus 1% 2,3-BD (Fig. 6). Because
sustained IL-8 mRNA synthesis requires sustained binding
of NF-B (35), the detection of elevated levels of IB
suggests that this protein is efficiently preventing the acti-
vation of the NF-B signaling pathway and thus suppressing
IL-8 gene transcription. Our NF-B reporter assays further
verified the reduction of NF-B-responsive promoter activ-
ity in the presence of 2,3-BD. Therefore, these data together
provide supporting evidence for our hypothesis that 2,3-BD
targets the NF-B signaling pathway at least as a part of the
mechanism to downregulate proinflammatory cytokine pro-
duction in host epithelial cells.
Our current research sheds light on the potential molecular
basis behind the biotype switch of the deadly enteric pathogen
V. cholerae from Classical to El Tor. Our findings suggest that
2,3-BD can suppress the activation of proinflammatory medi-
ators induced by bacterial products like flagella by modulating
the NF-B signaling pathway. Thus, the presence of excess
glucose in the human gut from ORS consumption or other
means may have contributed to the extinction of the Classical
biotype strains in two ways: (i) by decreasing the ambient pH
to a lethal range and (ii) by inducing higher levels of proin-
flammatory response against bacterial antigens. In contrast,
El Tor biotype strains might have acquired an evolutionary
advantage by metabolizing glucose to 2,3-BD and have been
a dominant pathogenic species in cholera pandemics. It was
reported that cholera patient stools were alkaline (pH  7)
(25). However, no further details were revealed with regard
to (i) the biotype of the causative strain, (ii) the levels and
types of cytokines present in the intestinal mucus of the
patients, and (iii) whether the patients that produced the
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same tested stools had been treated with the ORS. Such
information would collectively provide a better clue as to
whether the biotype-specific glucose metabolism indeed im-
pacts the differential host proinflammatory immune activa-
tion and, thus, survival of the two different biotype strains in
vivo.
Given these findings, we next propose to observe the
effect of 2,3-BD, a unique metabolite produced by V. chol-
erae El Tor biotype strains, on the innate immune activation
in a valid animal model system, as the present study inves-
tigated the production profile of simple biomarkers for pro-
inflammatory responses in cultured host epithelial cells.
Further in vivo studies will unambiguously verify the im-
mune-suppressive role of 2,3-BD. We also propose that pu-
rified 2,3-BD from bacterial fermentation products may
have potential to be developed as an anti-inflammatory
agent that could be used for therapy.
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